Susan Smith
Director/Board Member bei CLINUVEL PHARMACEUTICALS LIMITED
Vermögen: 3 935 $ am 31.03.2024
Profil
Susan Smith is currently the Chief Executive Officer at The Portland Hospital For Women & Children.
She is also the Vice Chairman at Clinuvel Pharmaceuticals Ltd., the Chairman at Evewell Group Ltd., and the Director at HCA Hope Fund.
Previously, she held the position of Chief Executive Officer at The Princess Grace Hospital and The Independent Doctors Federation.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.06.2023 | 420 ( 0,00% ) | 3 935 $ | 31.03.2024 |
Aktive Positionen von Susan Smith
Unternehmen | Position | Beginn |
---|---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Director/Board Member | 23.09.2019 |
Evewell Group Ltd. | Chairman | - |
HCA Hope Fund | Director/Board Member | - |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Part of HCA Healthcare, Inc., The Portland Hospital For Women & Children operates hospitals. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Susan Smith
Unternehmen | Position | Ende |
---|---|---|
The Princess Grace Hospital | Chief Executive Officer | - |
The Independent Doctors Federation | Chief Executive Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 5 |
---|---|
The Princess Grace Hospital | |
HCA Hope Fund | |
The Independent Doctors Federation | |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Part of HCA Healthcare, Inc., The Portland Hospital For Women & Children operates hospitals. | Health Services |
Evewell Group Ltd. |